Singapore Paincare Holdings Past Earnings Performance
Past criteria checks 0/6
Singapore Paincare Holdings's earnings have been declining at an average annual rate of -10.2%, while the Healthcare industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 30.1% per year.
Key information
-10.2%
Earnings growth rate
-86.0%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 30.1% |
| Return on equity | 0.8% |
| Net Margin | -1.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Singapore Paincare Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 25 | 0 | 0 | 0 |
| 30 Sep 23 | 24 | 0 | 0 | 0 |
| 30 Jun 23 | 22 | -1 | 0 | 0 |
| 31 Mar 23 | 22 | 1 | 1 | 0 |
| 31 Dec 22 | 22 | 2 | 1 | 0 |
| 30 Sep 22 | 21 | 3 | 1 | 0 |
| 30 Jun 22 | 19 | 4 | 1 | 0 |
| 31 Mar 22 | 17 | 4 | 1 | 0 |
| 31 Dec 21 | 15 | 4 | 0 | 0 |
| 30 Sep 21 | 13 | 3 | 0 | 0 |
| 30 Jun 21 | 11 | 2 | 0 | 0 |
| 31 Mar 21 | 11 | 2 | 0 | 0 |
| 31 Dec 20 | 10 | 1 | 0 | 0 |
| 30 Sep 20 | 10 | 2 | 0 | 0 |
| 30 Jun 20 | 10 | 2 | 0 | 0 |
| 31 Mar 20 | 9 | 2 | 0 | 0 |
| 31 Dec 19 | 7 | 2 | 0 | 0 |
| 30 Sep 19 | 6 | 2 | 0 | 0 |
| 30 Jun 19 | 4 | 1 | 1 | 0 |
| 30 Jun 18 | 4 | 1 | 0 | 0 |
| 30 Jun 17 | 4 | 1 | 0 | 0 |
Quality Earnings: FRQ is currently unprofitable.
Growing Profit Margin: FRQ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FRQ is unprofitable, and losses have increased over the past 5 years at a rate of 10.2% per year.
Accelerating Growth: Unable to compare FRQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FRQ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-2%).
Return on Equity
High ROE: FRQ has a negative Return on Equity (0.8%), as it is currently unprofitable.